The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Glioblastoma with Adipocyte‐Like Tumor Cell Differentiation—Histological and Molecular Features of a Rare Differentiation Pattern
Open accessAbstract
We report on three adult patients with primary glioblastomas showing prominent adipocytic (lipomatous) differentiation, hence referred to as “glioblastomas with adipocyte‐like tumor cell differentiation.” Histologically, the tumors demonstrated typical features of glioblastoma but additionally contained areas consisting of glial fibrillary acidic protein (GFAP)‐positive astrocytic tumor cells resembling adipocytes, that is, containing large intracellular lipid vacuoles. Comparative genomic hybridization (CGH) and focused molecular genetic analyses demonstrated gains of chromosomes 7, losses of chromosomes 9 and 10, as well as homozygous deletion of p14 ARF in one of the tumors. The second tumor showed gains of chromosomes 3, 4, 8q and 12 as well as losses of chromosomes 10, 13, 15q, 19 and 22. In addition, this tumor carried homozygous deletions of CDKN2A and p14 ARF as well as point mutations in the TP53 and PTEN genes. The third tumor also had a mutation in the PTEN gene. None of the tumors demonstrated EGFR, CDK4 or MDM2 amplification. Taken together, our results define a rare glioblastoma differentiation pattern and indicate that glioblastomas with adipocyte‐like tumor cell differentiation share common molecular genetic features with other primary glioblastomas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ARF deletion is correlated with overexpression of tectonic family member 1 (TCTN1), a protein involved in a diverse range of cellular processes, including promotion of GBM cell proliferation.”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [37]
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C. J., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 905
Self-citationSearches for ultimate chemical carcinogens and their reactions with cellular macromolecules
Miller, E. C., & MILLER, J. A. (1981) · Cancer · doi:10.1002/1097-0142(19810515)47:10 · Cited by 730
MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS
Louis, D. N. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100043 · Cited by 658
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H. R., Bignell, G. R., Edkins, S., Stevens, C., O’Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 443
PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Rasheed, B., Stenzel, T. T., McLendon, R. E., Parsons, R. E., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Bigner, S. H. (1997) · PubMed · Cited by 384
PTEN mutations in gliomas and glioneuronal tumors
Duerr, E., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer‐Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R. E., Eng, C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201756 · Cited by 345
Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199807000-00005 · Cited by 256
Riemenschneider, M. J., Büschges, R., Wolter, M., REIFENBERGER, J., Boström, J. P., Kraus, J. A., Schlegel, U. S., & Reifenberger, G. (1999) · PubMed · Cited by 247
Self-citation
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1227/00006123-199001000-00001 · DOI
Cited by
Sorted by citations
The p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Review Glioblastoma multiforme – an overview
Urbańska, K., Sokołowska, J., Szmidt, M., & Sysa, P. (2014) · Współczesna Onkologia · doi:10.5114/wo.2014.40559 · Cited by 300
Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population
Harthi, F. S. A., Qari, A., Edress, A., & Abedalthagafi, M. (2020) · npj Genomic Medicine · doi:10.1038/s41525-019-0110-y · Cited by 43
PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Zhang, H., Zhou, Y., Cheng, Q., Dai, Z., Wang, Z., Liu, F., Fan, F., Cui, B., & Cao, H. (2020) · Aging · doi:10.18632/aging.103601 · Cited by 42
The effect of lipid metabolism on cuproptosis-inducing cancer therapy
Zhong, Y., Zeng, W. G., Chen, Y., & Zhu, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116247 · Cited by 24
Metadata
- Authors
- Rickert, C. H., Riemenschneider, M. J., Schachenmayr, W., Richter, H., Bockhorn, J., Reifenberger, G., & Paulus, W.
- Affiliations
- Royal Children's Hospital (AU)
- Heinrich Heine University Düsseldorf (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- University Hospital Ulm (DE)
- Bayreuth Medical Center (DE)
- University Hospital Münster (DE)
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2009-06-10
- Volume
- 19
- Issue
- 3
- Pages
- 431-438
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- PMC
- PMC8094827
- OpenAlex
- W2043449331
- Cited by
- 23
- References
- 39
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- glioblastoma, lipomatous differentiation, glial fibrillary acidic protein, chromosome gains and losses, CDKN2A deletion, TP53 mutation, PTEN mutation, molecular genetic features
- MeSH terms
- Aged, Brain Neoplasms, Cell Differentiation, DNA Mutational Analysis, Female, Glioblastoma, Humans, Immunohistochemistry, Male, Middle Aged, Polymerase Chain Reaction, Adipocytes, Polymorphism, Single-Stranded Conformational, Microscopy, Electron, Transmission, Comparative Genomic Hybridization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
